Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2008 3
2009 2
2010 5
2011 6
2012 5
2013 8
2014 7
2015 11
2016 10
2017 14
2018 14
2019 17
2020 40
2021 54
2022 34
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Clinical Trial.
Microbiota and prostate cancer.
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Rizzo A, et al. Among authors: brandi g. Semin Cancer Biol. 2022 Nov;86(Pt 3):1058-1065. doi: 10.1016/j.semcancer.2021.09.007. Epub 2021 Sep 15. Semin Cancer Biol. 2022. PMID: 34536504 Review.
Cholangiocarcinoma: Epidemiology and risk factors.
Khan SA, Tavolari S, Brandi G. Khan SA, et al. Among authors: brandi g. Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24. Liver Int. 2019. PMID: 30851228 Review.
In Reply.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S. Brandi G, et al. Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807301 Free PMC article.
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma.
Carloni R, Sabbioni S, Rizzo A, Ricci AD, Palloni A, Petrarota C, Cusmai A, Tavolari S, Gadaleta-Caldarola G, Brandi G. Carloni R, et al. Among authors: brandi g. J Hepatocell Carcinoma. 2023 Sep 6;10:1445-1463. doi: 10.2147/JHC.S390963. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37701562 Free PMC article. Review.
Hot topics in cholangiocarcinoma.
Brandi G. Brandi G. Transl Cancer Res. 2019 Apr;8(Suppl 3):S219-S222. doi: 10.21037/tcr.2018.08.18. Transl Cancer Res. 2019. PMID: 35117102 Free PMC article. No abstract available.
BAP1 in solid tumors.
Di Nunno V, Frega G, Santoni M, Gatto L, Fiorentino M, Montironi R, Battelli N, Brandi G, Massari F. Di Nunno V, et al. Among authors: brandi g. Future Oncol. 2019 Jun;15(18):2151-2162. doi: 10.2217/fon-2018-0915. Epub 2019 Jun 4. Future Oncol. 2019. PMID: 31159579 Review.
Asbestos and Intrahepatic Cholangiocarcinoma.
Brandi G, Tavolari S. Brandi G, et al. Cells. 2020 Feb 12;9(2):421. doi: 10.3390/cells9020421. Cells. 2020. PMID: 32059499 Free PMC article. Review.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators. Zhu AX, et al. Among authors: brandi g. Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18. Lancet Oncol. 2019. PMID: 30665869 Clinical Trial.
223 results